Lv1
30 积分 2022-05-23 加入
Cannabinoformins: Designing Biguanide-Embedded, Orally Available, Peripherally Selective Cannabinoid-1 Receptor Antagonists for Metabolic Syndrome Disorders
1个月前
已完结
Chromatin-targeted drug discovery at “a very special moment”
1个月前
已完结
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models
1个月前
已完结
Tirzepatide Once Weekly for the Treatment of Obesity
2个月前
已完结
Binding sites and design strategies for small molecule GLP-1R Agonists
3个月前
已完结
The GLP-1R as a model for understanding and exploiting biased agonism in next-generation medicines
3个月前
已完结
皖公网安备34019202002308
